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Abstract
BACKGROUND: Keloid is a benign fibroproliferative dermis tumor characterized by an increase in growth factors 
which induce fibroblast proliferation, excessive migration, and synthesis of collagen. Nerium indicum Mill. extract 
had been studied as a keloid therapy agent. 5α-oleandrin contained in N. indicum has antikeloid activity by inhibiting 
keloid fibroblast proliferation, fibroblast migration, collagen deposition, and transforming growth factor beta-1 (TGF-
β1) synthesis.
OBJECTIVE: This study aimed to determine the effect of administration of N. indicum extract on TGF-β1 and 
vascular endothelial growth factor (VEGF) expression in keloid fibroblast.
METHODS: This research was a quasi-experimental research with a post-test only control group design. The 
research subjects were fibroblast cells passage IV-VII isolated from patients’ keloid tissue with explant techniques. 
Treatment groups received N. indicum extract with a serial concentration of 2 µg/ml, 1 µg/ml, and 0.5 µg/ml, and 
control group received medium only. The supernatant was obtained after 72 h incubation period. Examination of 
TGF-β1 and VEGF expressions was performed using ELISA procedure.
RESULT: The expression of TGF-β1 in the treatment groups of the extract N. indicum (2 µg/ml, 1 µg/ml, and 0.5 µg/ml) 
was significantly lower than a control group of keloid fibroblasts (p < 0.05), according to increased concentration. 
VEGF expression in the treatment groups of N. indicum extract was lower compared to the control group of keloid 
fibroblasts. A significant decrease in keloid fibroblast VEGF levels occurred at extract concentrations of 2 µg/ml and 
1 µg/ml (p < 0.05).
CONCLUSION: N. indicum extract could decrease TGF-β1 and VEGF expressions compared to control medium in 
keloid fibroblast cultures.
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Introduction
Keloid is a dermal fibroproliferation tumor 
characterized by excessive accumulation of extracellular 
matrix (ECM) components such as collagen, fibronectin, 
elastin, proteoglycans, and growth factors [1]. The 
occurrence of keloids is due to an imbalance between 
synthesis and degradation of ECM during the wound 
healing process [2]. In the pathogenesis of keloids, 
fibroblasts are the dominant cell and keloid fibroblasts 
have a greater proliferative ability than normal fibroblasts. 
Increased proliferation of keloid fibroblasts is influenced 
by increased growth factors such as transforming 
growth factor-beta (TGF-β), vascular endothelial growth 
factor (VEGF), fibroblast growth factors, platelet-
derived growth factor (PDGF), and cytokines’ tumor 
necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and 
interleukin-6 (IL-6) [3]. Increased TGF-β1 will accelerate 
mitogenesis of fibroblasts, stimulating the formation 
of collagen, elastin, and fibronectin. Furthermore, 
VEGF induces angiogenesis directly through 
endothelial cell mitogenesis and lead increases 
vascular permeability and promotes deposition of 
extravascular fibrin matrix [4]. Keloid management 
is currently lacking satisfactory results. For example, 
keloid excision surgical therapy had a recurrence 
of 45–100% while non-surgical therapy had various 
side effects such as skin atrophy, telangiectasias, 
and pigmentation disorders [5]. Various studies were 
done using plants/herbs that have the potential as 
keloid therapy agents and milder side effects. Nerium 
indicum Mill. containing active ingredient Oleandrin 
has been studied potentially as a keloid therapy 
agent. Oleandrin cytotoxicity (IC50 15.6 nM) was 
greater than doxorubicin (IC50 26.9 nM) and cisplatin 
(IC50 79.8 nM) on M19 cell line (melanoma) [6], [7]. 
5α-oleandrin has antikeloid activity by inhibiting keloid 
fibroblast proliferation, fibroblast migration, collagen 
deposition, and TGF-β1 synthesis [8]. Ethanolic extract 
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N. indicum inhibits proliferation of keloid fibroblasts with 
IC50 0.458 µg/ml, also can inhibit collagen deposit with 
IC50 0.055 µg/ml at 72 h incubation period. In incubation 
48 h after administration of ethanol extract of N. indicum 
1 µg/ml, there was a significant inhibition of migration 
compared to the control medium [9]. Therefore, based 
on the above exposures, this study aimed to determine 
the molecular mechanism of N. indicum extract activity 
on the expressions of TGF-β1 and VEGF which play an 
important role in pathogenesis of keloid tumors.
Materials and Methods
Keloid fibroblast cultured cell
This research received approval from the 
Medical and Health Research Ethics Committee of 
the Faculty of Medicine, Public Health and Nursing 
Universitas Gadjah Mada based on the Certificate of 
Ethical Eligibility number: KE/FK/0485/EC/2018. This 
research was a quasi-experimental research with post-
test only control group design.
Keloid fibroblasts used were a subculture 
passage IV-VII, obtained from the Laboratory of Health 
Technology, Dermatology Venereology Division, Faculty 
of Medicine, Public Health and Nursing Universitas 
Gadjah Mada. Materials used were N. indicum leaves 
collected from Sleman-Yogyakarta Special District of 
Indonesia on May 2018, identified at the laboratory 
plant systematics, and voucher specimen no: UGM/
FA/4533/M/03/02 deposited in the Laboratory of Plant 
Systematics, Faculty of Pharmacy, Universitas Gadjah 
Mada. Additional materials included amphotericin 
B-Fungizone (GibcoTM), Dulbecco’s Modified Eagle’s 
Medium Low Glucose (Gibco), dimethyl sulfoxide 
(DMSO) (Merck), MTT (Sigma), penicillin-streptomycin 
(Gibco BRL), phosphate buffer saline (Gibco), Povidone-
iodine 10% (Gibco), and Trypsin EDTA 0.25% (Gibco).
Extraction of N. indicum
About 1 kg of dried powder from N. indicum 
leaves was macerated by ethanol (70%) (2 L). The 
mixture was stirred periodically for 24 h. The filtrate 
was separated by filtration (Buchner funnel), and 
maceration was repeated 3 times. The filtrates obtained 
were combined and evaporated in vacuo to dryness.
Tested concentration preparation
Ethanol extract of N. indicum as much as 
5 mg was dissolved with 100 μL of DMSO to obtain 
a stock solution concentration of 50,000 μg/ml. The 
stock solution concentration was made into three serial 
levels: 0.5 µg/ml, 1 µg/ml, and 2 µg/ml.
The 24 well plate culture preparation
Cell suspension was counted based on a 
number of groups in the study in triplicate. Fibroblast 
cell culture was harvested, washed, and made into 
suspension. Cells (3 × 104 cells/well) were seeded into 
24 well plates and further incubated with N. indicum 
extract (0.5; 1; and 2 µg/ml) and control medium for 72 h.
Measurement of TGF-β1 expression
The protocol of TGF-β1 measurement was 
performed according to the procedure issued by Koma 
Biotech Inc. as the manufacturer of the human TGF-β1 
with Catalog No: K0332110.
Measurement of VEGF expressions
The protocol of VEGF measurement was 
performed according to the procedure issued by Koma 
Biotech Inc. as the manufacturer of the human VEGF 
with Catalog No: K0331132.
Statistical analysis
All data are expressed as means ± standard 
deviation (SD). Differences between control and 
experimental groups were analyzed by one-way ANOVA 
followed by Bonferonni’s post-hoc test, with p < 0.05 
considered as statistically significant. All calculations 
were performed using SPSS statistical software (IBM 
Corp., Chicago).
Results
TGF-β1 expression
The expressions of TGF-β1 statistically 
significance of N. indicum extract with various 
concentrations 0.5 µg/ml (9.27 ± 2.9 pg/ml), 1 µg/ml 
(9.26 ± 2.32 pg/ml), and 2 µg/ml (6.23 ± 2.02 pg/ml) 
were lower than control group (21.35 ± 5.03 pg/ml). 
The effect of the ethanolic extract of N. indicum on the 
expression of TGF-β1 in keloid fibroblasts is shown in 
Figure 1.
Figure 1 shows that TGF-β1 expression was 
significantly lower in the ethanolic extract N. indicum 
groups compared to those in keloid fibroblast without 
treatment, according to increased concentration 
(p < 0.05).
VEGF expression
The expression of VEGF supernatant in treatment 
groups of N. indicum extract with various concentration 
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0.5 µg/ml (38.31 ± 8.46 pg/ml), 1 µg/ml (28.57 ± 
4.53 pg/ml), and 2 µg/ml (20.14 ± 1.5 pg/ml) were lower 
than control group (50.33 ±12.59 pg/ml).The effect of 
ethanolic extract of N. indicum on the expression of 
VEGF in keloid fibroblasts is shown in Figure 2.
medium group, which showed the antikeloid effect of 
N. indicum ethanol extract. A significant decrease in 
keloid fibroblast TGF-β1 levels occurred at all of the 
N. indicum extract concentrations (2 µg/ml, 1 µg/ml, 
and 0.5 µg/ml) compared to those in the control group 
(p < 0.05). This is in accordance with previous studies 
by Dachlan (2019) that showed 5α-oleandrin isolates 
from ethanol extraction of N. indicum leaves significantly 
decreased TGF-β1 expression compared to control 
medium (p < 0.05) [8]. Increased TGF-β1 activity in 
fibroblast cells can enlarge the ability to stimulate tissue 
remodeling and the excessive process of wound healing 
causes keloid tissue. TGF-β1 plays an important role 
in pathogenesis of fibrosis because of its ability to 
initiate and maintain activation of keloid fibroblasts. The 
downstream pathway of TGF-β1 signaling is activated 
by Smad 2/3 protein which regulates increased 
proliferation in fibroblast cells as well as transcription 
factors that can activate genes which produce cytokines 
and TGF-β1 [10]. The presence of increased TGF-β1 
in keloids can also induce transcription factor activator 
protein-1 (AP-1) which increases collagen type 1 
production and extracellular protein synthesis [11]. In 
addition, there is also a 6/7 Smad protein which plays 
a role in Smad 2/3 activation termination (negative 
feedback). Protein inhibition of Smad 2/3 can suppress 
genes that produce TGF-β1, type I collagen synthesis, 
and decrease ECM deposition so that it can inhibit 
fibrosis [12], [13].
The active compound Oleandrin contained 
in N. indicum extract can inhibit activation of signal 
transduction such as AP-1 which is mediated through 
inhibition of JNK and MEK, thereby suppressing the 
genes that synthesize TGF-β1 growth factor [14]. There 
are obstacles of TGF-β1 signaling activity from the active 
compound Oleandrin contained in N. indicum extract 
which can be an indicator that supports keloid therapy. 
Mechanical transduction is also reported to affect cell 
function. On the surface of keloid tissue, there is often 
a higher mechanical emphasis than the surrounding 
tissue, and this is influenced by the expression of TGF-
β1 which can regulate the expression of smooth muscle 
actin (SMA). TGF-β1 can increase cell rigidity through 
interactions between TGF-β1 receptors and SMA axis 
so that it can also be targeted for keloid therapy [15]. 
Recent research using TGF-β1 oligonucleotide can 
provide long-term effects in inhibiting fibrosis both 
in vitro and in vivo. Administration of anti-TGF-β1 
antibodies in experimental animals was also reported 
to reduce fibrosis [16].
In this study, the VEGF-A expression of keloid 
fibroblasts was measured at the concentration of 
N. indicum 2 µg/ml and 1 µg/ml extract and showed 
a significantly lower level compared to the control 
medium (p < 0.05). This finding is in accordance 
with the research of Wahyuningsih et al. in 2018 that 
found ethanolic extract of N. indicum can inhibit the 
proliferation of keloid fibroblasts for a 48-h incubation 
period [8]. In another study, the administration of taginin 
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Figure  1:  Effect  of  Nerium indicum  extract  on  keloid  fibroblasts 
transforming growth factor beta-1 expression (mean ± standard 
deviation). Description: FK=Fibroblasts keloid, N. indicum extract 
concentrations 0.5 µg/ml; 1 µg/ml; 2 µg/ml. * p < 0.05 versus 
control FK
Figure  2:  Effect  of  Nerium indicum  extract  on  keloid  fibroblasts 
vascular endothelial growth factor expression (means ± standard 
deviation). Description: FK= Fibroblasts Keloid, N. indicum extract 
concentrations 0.5 µg/ml; 1 µg/ml; 2 µg/ml. *p < 0.05 versus 
control FK
VEGF-A expression of keloid fibroblasts at the 
concentration of N. indicum 2 µg/ml and 1 µg/ml extract 
showed a significantly lower VEGF-A level compared to 
the medium control (p < 0.05).
Discussion
Our study was able to find lower expression 
in TGF-β1 and VEGF levels in N. indicum Mill. 
extract treatment groups compared to the control 
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C isolates from plants significantly reduced VEGF-A 
expression in keloid fibroblast cultures compared to the 
control medium group (p < 0.05) [17].
Oleandrin compounds from N. indicum extract 
have a steroid chemical structure that can bind to 
glucocorticoid receptors (GR) on keloid fibroblast cells 
so that they can inhibit transcription factor signaling 
which induces genes’ expression of VEGF-A. In 
addition, the lactone chemical structure which is also 
present in Oleandrin plays a role in signaling pathway 
receptor tyrosine kinase (VEGFR) through inhibition of 
extracellular regulated kinase (ERK) proteins so that 
VEGFR phosphorylation does not occur [18].
VEGF-A is an active protein homodimer that 
plays a role in angiogenesis. Angiogenesis occurs 
together with fibroplasia and is interdependent. Collagen 
and ECM when formed must always get oxygen and 
nutrients so that metabolic processes can occur [19]. 
Some of the most important mechanisms for regulating 
VEGF-A are hypoxia. The hypoxic condition will induce 
a hypoxia-inducible factor-1alpha (HIF-1ɑ) to bind with 
VEGF receptors, triggering the tyrosine kinase pathway 
to angiogenesis [20]. Some cytokines and other growth 
factors can also increase VEGF-A expression. TNF-α 
is an inflammatory cytokine that has a strong biological 
activity to increase VEGF-A. Other cytokines such as 
IL-1 and IL-6 can also stimulate VEGF-A. Other growth 
factors such as TGF-β, EGF, and PDGF-BB can also 
induce VEGF-A [21].
In keloid tumors, there is an increased 
VEGF expression that binds to the VEGFR receptor, 
activating signaling pathways for angiogenesis and 
neovascularization of tyrosine kinase. Activation of 
VEGFR by VEGF-A causes autophosphorylation of 
tyrosine residues at the VEGFR receptors, thereby 
activating mitogen-activated protein-kinase (MAP-
K) which causes cell proliferation and migration as 
well as activation of AKT/ERK proteins producing 
eNOS so that vascular permeability increases [22]. 
Fibrosis in keloid tissue is caused by increased 
VEGF-A phosphorylation with its receptors. Increased 
VEGF-A can occur exogenously and endogenously. 
Exogenous VEGF-A will increase the phosphorylation 
of VEGFR-A receptors, thereby increasing proliferation 
of keloid fibroblasts, while endogenous VEGF-A will 
increase the activation of transcription factors from 
VEGF-A and IGF gene expressions in keloid tissue 
fibroblasts [18], [19].
Conclusion
Based on the results of this research, it can 
be concluded that the ethanolic extract of N. indicum 
Mill. can decrease expressions of TGF-β1 and VEGF in 
keloid fibroblast cultures. Further research is necessary 
to examine the effect of N. indicum extract on Smad 2/3 
and Smad 6/7 expressions, as well as the expression 
of AP-1 transcription factors in keloid fibroblasts to 
support the molecular mechanism of N. indicum extract 
as a keloid therapy agent.
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